recognised that confirmation of active SARS-CoV-2 infection in pre-symptomatic and asymptomatic individuals is crucial to contain transmission both in hospitals and in the community (4). Population surveillance, screening of those working with, or in, high-risk populations (7-8) and contact tracing (5-6) will be important strategies to prevent and control future outbreaks. However, rapid intensification of testing in many countries has led to shortages of molecular diagnostics and reagents, and places substantial burdens on laboratory systems with limited capacity (1). There is an urgent need to develop and validate approaches, which can overcome resource constraints and the practical challenges of testing large numbers of people (1).
|Publication status||Accepted/In press - 10 Sep 2020|